High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed BBB under flow in vitro

Authors	Soldati S, Bär A, Vladymyrov M, Glavin D, McGrath J, Gosselet F, Nishihara H, Goelz S, Engelhardt B.
Journal	J Neuroinflammation
Publication Date	2023-01-01